Answers are grounded in this paper and cite their sources.
The microbiota–gut–brain axis is a bidirectional communication network linking the intestinal environment with the brain and plays a central role in systemic homeostasis and human health. Disruption of this axis has been repeatedly associated with chronic diseases, including neuropsychiatric disorders. Increasing evidence suggests that selected probiotics and prebiotics, termed psychobiotics, may support mental health through humoral, neural, endocrine, and immune-mediated pathways. This narrative review summarizes animal and human studies to clarify how psychobiotics influence behavioral, cognitive, and emotional processes by modulating the microbiota–gut–brain axis. Preclinical studies consistently show that Lactobacillus and Bifidobacterium strains affect gut–brain signaling through the production of neuroactive compounds and regulation of host genes involved in stress and inflammation. Clinical findings partly support these effects in specific patient populations. Psychobiotics may represent safe, accessible interventions, but stronger validation is needed before routine clinical use and precision psychiatry. Further multidisciplinary research should define mechanisms, responders, and optimal formulations.
No takes yet. Share an insight, caveat, or question.
Karaivazoglou et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: